News

A new study from University of Copenhagen researchers explains how some multidrug-resistant bacteria are able to survive lethal doses of antibiotics through a hibernation-like defense mechanism.

Researchers use protein misfolding cyclic amplification to screen blood samples for abnormal prions that would indicate Creutzfeldt-Jakob disease (CJD).

Experts suggest government efforts are sorely needed to provide education about HIV/AIDS to at-risk groups, especially among the young gay population.

Researchers from the University of Würzburg in Germany discuss the use of marine natural products to fight drug-resistant pathogens.

Researchers from Australia may have found the key to the spread of antimicrobial-resistant gonorrhea in men who have sex with men (MSM).

A review of the top two video interviews from 2016 is included here.

In Arizona and California, where coccidioidomycosis, or Valley fever, is most prevalent, researchers are putting new federal funding to use to study these fungal infections.

Researchers from Erasmus disease the key factors needed for successful human-to-human contact-transmission of zoonotic pathogens.

Johns Hopkins University School of Medicine researchers have found that genetic mutations of the NOD1 protein can result in increased risk of cytomegalovirus (CMV).

With an increase in attention on arthropod-borne diseases this year, scientists from Erasmus discuss the key factors involved in human-to-human transmission of these pathogens.

Despite the largest mumps outbreak in the United States in a decade, health officials note that the outbreak would have been larger and more severe without high vaccination rates.

Contagion’s Top Five Zika-related news stories over the past year are included in this article.

The 90-90-90 goal from the Joint UN Programme on HIV/AIDS has three prongs: By 2020, 90% of people with HIV worldwide will be aware of their status; 90% of HIV+ people will have access to treatment; and 90% of those with HIV will have a suppressed viral load. Money and training are key.

Researchers have found that current methods of predicting risk of heart attack or stroke in HIV-positive individuals are lacking.

On December 14, the Centers for Disease Control and Prevention (CDC) issued a Zika-related travel and testing guidance for Brownsville, Texas and the surrounding area after local officials confirmed 5 cases of the virus linked to local mosquitoes.

With an increasing number of Salmonella infections showing resistance to antibiotics, a CDC team set out to determine which strains are most problematic.

Researchers shed light on how oxylipins play a key role in forming the biofilm shield that helps protect disease-causing bacteria against antibiotics.

We’ve put together the top five biggest news stories regarding food-borne illnesses this year. Did you see them all?

A new study reveals evidence that a longer course of antibiotics is more effective for treating ear infections in young children.

Researchers have found that an experimental vaccine designed to fight the Ebola virus has proven to be highly protective.

Today, the US Food and Drug Administration (FDA) released a safety document cautioning healthcare providers from relying solely on commercial IgM Assay results when diagnosing Zika, as false positives have been observed.

A recent study found that azithromycin topical gel can protect against Lyme disease if administered within 72 hours of a tick bite.

Under a program established through the Affordable Care Act, 769 US hospitals will receive Medicare reimbursement reductions due to the high rates of hospital-acquired infections.

The European Medicines Agency (EMA) released guidelines recommending screening for hepatitis B in patients who are infected with hepatitis C prior to starting treatment with direct-acting antivirals.

Health officials in China have reported six recent human cases of bird flu in three mainland provinces and the Macao Special Administrative Region; these cases have been traced back to live poultry markets and poultry farms.

The first large-scale clinical trial of a new HIV preventive drug, cabotegravir, has been launched and researchers are looking to see if it is just as effective as Truvada, the only licensed PrEP regimen currently available.

Although herpes remains one of the most prevalent sexually transmitted infections in the United States, the US Preventive Services Task Force is calling for less routine testing.

A DNA-based Zika virus vaccine developed by Inovio Pharmaceuticals proves successful in phase I open-label dose-ranging human trials.